Venous plasma levels of endothelin-1 are not altered immediately after nitroglycerin infusion in healthy subjects
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Venous plasma levels of endothelin-1 are not altered immediately after nitroglycerin infusion in healthy subjects. / Thomsen, L L; Iversen, Helle Klingenberg; Emmeluth, C; Bie, P.
In: European Journal of Clinical Pharmacology, Vol. 48, No. 2, 1995, p. 139-42.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Venous plasma levels of endothelin-1 are not altered immediately after nitroglycerin infusion in healthy subjects
AU - Thomsen, L L
AU - Iversen, Helle Klingenberg
AU - Emmeluth, C
AU - Bie, P
PY - 1995
Y1 - 1995
N2 - Endothelin-1 and nitric oxide play an important regulatory role in the control of vascular smooth muscle tone. Nitroglycerin (NTG), a nitric oxide donating drug, may inhibit endothelin production. In this double-blind placebo-controlled crossover study, plasma levels of endothelin-1 were measured before and immediately (5-30 s) after 80 min infusion of NTG (glyceryl trinitrate) or saline in 12 healthy subjects. On two different days separated by at least 1 week, NTG in four different doses, 0.015, 0.25, 1.0, and 2.0 micrograms. kg-1. min-1, or placebo (isotonic saline) was infused successively for 20 min each dose. During the infusion blood pressure and heart rate were measured. NTG infusion significantly decreased systolic blood pressure from 112.4 to 103.4 mmHg and pulse pressure from 39.3 to 29.5 mmHg. Heart rate increased from 62.7 to 73.1 beats. min-1. No changes in endothelin-1 plasma levels were induced by NTG infusion (2.4 pg.ml-1 before NTG vs. 2.7 pg.ml-1 after NTG) and placebo infusion also did not affect plasma endothelin-1. It is concluded that venous plasma levels of endothelin-1 are not altered immediately after NTG infusion.
AB - Endothelin-1 and nitric oxide play an important regulatory role in the control of vascular smooth muscle tone. Nitroglycerin (NTG), a nitric oxide donating drug, may inhibit endothelin production. In this double-blind placebo-controlled crossover study, plasma levels of endothelin-1 were measured before and immediately (5-30 s) after 80 min infusion of NTG (glyceryl trinitrate) or saline in 12 healthy subjects. On two different days separated by at least 1 week, NTG in four different doses, 0.015, 0.25, 1.0, and 2.0 micrograms. kg-1. min-1, or placebo (isotonic saline) was infused successively for 20 min each dose. During the infusion blood pressure and heart rate were measured. NTG infusion significantly decreased systolic blood pressure from 112.4 to 103.4 mmHg and pulse pressure from 39.3 to 29.5 mmHg. Heart rate increased from 62.7 to 73.1 beats. min-1. No changes in endothelin-1 plasma levels were induced by NTG infusion (2.4 pg.ml-1 before NTG vs. 2.7 pg.ml-1 after NTG) and placebo infusion also did not affect plasma endothelin-1. It is concluded that venous plasma levels of endothelin-1 are not altered immediately after NTG infusion.
KW - Adult
KW - Blood Pressure
KW - Double-Blind Method
KW - Endothelins
KW - Female
KW - Heart Rate
KW - Humans
KW - Injections, Intravenous
KW - Male
KW - Nitric Oxide
KW - Nitroglycerin
KW - Time Factors
M3 - Journal article
C2 - 7589028
VL - 48
SP - 139
EP - 142
JO - European Journal of Clinical Pharmacology
JF - European Journal of Clinical Pharmacology
SN - 0031-6970
IS - 2
ER -
ID: 128984171